eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
our partners
.
.
.
official guidelines say no one should wait more than 62 days to get cancer care after an urgent referral by their gp.
.
.
.
customize your news feed by choosing the topics that interest you.
.
august 2013 (15)
.
december 2012 (18)
.
when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected.
.